Inventor
WESKE MICHAEL
DE20 patents
⚠️ This page may combine multiple inventors who share the name “WESKE MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SOLVAY PHARM GMBH
10 patentsUS7368582B2May 6, 2008
Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
SOLVAY PHARM GMBH11 citations81
US7238470B2Jul 3, 2007
Method of treating or inhibiting obesity
SOLVAY PHARM GMBH9 citations71
US6946243B2Sep 20, 2005
Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
SOLVAY PHARM GMBH4 citations71
US7427611B2Sep 23, 2008
Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SOLVAY PHARM GMBH2 citations59
US7410962B2Aug 12, 2008
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SOLVAY PHARM GMBH2 citations59
US7262184B2Aug 28, 2007
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SOLVAY PHARM GMBH2 citations59
US7282325B2Oct 16, 2007
Method of preparing pharmaceutical compositions
SOLVAY PHARM GMBH0 citations50
US7714150B2May 11, 2010
Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
SOLVAY PHARM GMBH0 citations49
US7534903B2May 19, 2009
Use of amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease states
SOLVAY PHARM GMBH0 citations49
US7452875B2Nov 18, 2008
Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SOLVAY PHARM GMBH0 citations49
SOLVAY PHARM BV
5 patentsUS7189525B2Mar 13, 2007
Human enzymes of the metalloprotease family
SOLVAY PHARM BV5 citations70
US6855532B2Feb 15, 2005
Human enzymes of the metalloprotease family
SOLVAY PHARM BV3 citations59
US7312321B2Dec 25, 2007
Antibody to human enzymes of the metalloprotease family
SOLVAY PHARM BV0 citations49
US7083965B2Aug 1, 2006
Human enzymes of the metalloprotease family
SOLVAY PHARM BV0 citations49
US7232813B2Jun 19, 2007
Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders
SOLVAY PHARM BV0 citations36